Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • T vs MRNA✓SelectedUSD · MRNAT vs MRNA performance historyLatest closeAs of-0.46%11/19
Stock and ETF performance explorer

T vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+66.6%
MRNA return
+806.0%
Excess return
-739.4%
Maximum drawdown
-39.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.5%+1.3%-1.7%-0.5%
7D-1.5%-13.8%+12.4%-1.4%
30D-6.7%-17.7%+11.0%-6.6%
3M-12.0%+14.3%-26.3%-12.2%
6M-10.4%+336.0%-346.3%-12.3%
YTD-7.8%+575.9%-583.8%-10.8%
1Y-9.4%+724.4%-733.8%-12.7%
3Y+59.7%+160.8%-101.0%+56.6%
5Y+59.8%-24.4%+84.2%+58.9%
All+66.6%+806.0%-739.4%+48.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling